Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies.

Rohr UP, Herrmann P, Ilm K, Zhang H, Lohmann S, Reiser A, Muranyi A, Smith J, Burock S, Osterland M, Leith K, Singh S, Brunhoeber P, Bowermaster R, Tie J, Christie M, Wong HL, Waring P, Shanmugam K, Gibbs P, Stein U.

Ann Oncol. 2017 Aug 1;28(8):1869-1875. doi: 10.1093/annonc/mdx207.

PMID:
28460000
2.

The evolution of genomic stability to a mechanism in reproduction and psychiatry.

Regidor PA, Volko CD, Schindler AE, Rohr UD.

Horm Mol Biol Clin Investig. 2017 Jan 1;29(1):1-11. doi: 10.1515/hmbci-2016-0013. Review.

PMID:
27269896
3.

Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer.

Ghosh P, Tie J, Muranyi A, Singh S, Brunhoeber P, Leith K, Bowermaster R, Liao Z, Zhu Y, LaFleur B, Tran B, Desai J, Jones I, Croxford M, Jover R, Goel A, Waring P, Hu S, Teichgraber V, Rohr UP, Ridder R, Shanmugam K, Gibbs P.

Clin Cancer Res. 2016 Jul 15;22(14):3488-98. doi: 10.1158/1078-0432.CCR-15-2290. Epub 2016 Mar 30.

4.

The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report.

Rohr UP, Binder C, Dieterle T, Giusti F, Messina CG, Toerien E, Moch H, Schäfer HH.

PLoS One. 2016 Mar 4;11(3):e0149856. doi: 10.1371/journal.pone.0149856. eCollection 2016. Erratum in: PLoS One. 2016;11(4):e0154008.

5.

Model approach for stress induced steroidal hormone cascade changes in severe mental diseases.

Volko CD, Regidor PA, Rohr UD.

Horm Mol Biol Clin Investig. 2016 Mar;25(3):157-70. doi: 10.1515/hmbci-2015-0038.

6.

Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests.

Vyberg M, Nielsen S, Røge R, Sheppard B, Ranger-Moore J, Walk E, Gartemann J, Rohr UP, Teichgräber V.

BMC Health Serv Res. 2015 Aug 29;15:352. doi: 10.1186/s12913-015-1018-6.

7.

Comparison of steady state development and reduction of menopausal symptoms after oral or transdermal delivery of 17-β-estradiol in young healthy symptomatic menopausal women.

Rohr UD, Volko CD, Schindler AE.

Horm Mol Biol Clin Investig. 2014 Jun;18(3):123-36. doi: 10.1515/hmbci-2013-0047.

PMID:
25390008
8.

The Impact of Design Modifications on the Mechanical Properties of a Polymeric Slotted Tube Coronary Stent.

Schümann K, Grabow N, Martin H, Röhr U, Sternberg K, Schmitz KP.

Biomed Tech (Berl). 2013 Aug;58 Suppl 1. pii: /j/bmte.2013.58.issue-s1-D/bmt-2013-4112/bmt-2013-4112.xml. doi: 10.1515/bmt-2013-4112. Epub 2013 Sep 7. No abstract available.

PMID:
24042747
9.

The effect of fermented soy (FSWW08) on blood hematology and cachexia in cancer patients.

Rohr UD, Li WW, Ziqiang H, Wainright W, Schindler AE.

Horm Mol Biol Clin Investig. 2012 Dec;12(3):407-18. doi: 10.1515/hmbci-2012-0028.

PMID:
25436700
10.

Balancing steroidal hormone cascade in treatment-resistant veteran soldiers with PTSD using a fermented soy product (FSWW08): a pilot study.

Gocan AG, Bachg D, Schindler AE, Rohr UD.

Horm Mol Biol Clin Investig. 2012 Jun;10(3):301-14. doi: 10.1515/hmbci-2011-0135.

PMID:
25436688
11.

Characteristics of highly impaired children with severe chronic pain: a 5-year retrospective study on 2249 pediatric pain patients.

Zernikow B, Wager J, Hechler T, Hasan C, Rohr U, Dobe M, Meyer A, Hübner-Möhler B, Wamsler C, Blankenburg M.

BMC Pediatr. 2012 May 16;12:54. doi: 10.1186/1471-2431-12-54.

12.

Managing immunity in resistant cancer patients correlates to survival: results and discussion of a pilot study.

Gocan AG, Bachg D, Schindler AE, Rohr UD.

Horm Mol Biol Clin Investig. 2011 Nov 1;8(2):455-69. doi: 10.1515/HMBCI.2011.122.

PMID:
25961344
13.

Venous thromboembolic events with chemotherapy plus bevacizumab: a pooled analysis of patients in randomized phase II and III studies.

Hurwitz HI, Saltz LB, Van Cutsem E, Cassidy J, Wiedemann J, Sirzén F, Lyman GH, Rohr UP.

J Clin Oncol. 2011 May 1;29(13):1757-64. doi: 10.1200/JCO.2010.32.3220. Epub 2011 Mar 21.

PMID:
21422411
14.

Cancer protection of soy resembles cancer protection during pregnancy.

Rohr UD, Gocan AG, Bachg D, Schindler AE.

Horm Mol Biol Clin Investig. 2010 Dec 1;3(2):391-409. doi: 10.1515/HMBCI.2010.063.

PMID:
25961211
15.

Bevacizumab safety in patients with central nervous system metastases.

Besse B, Lasserre SF, Compton P, Huang J, Augustus S, Rohr UP.

Clin Cancer Res. 2010 Jan 1;16(1):269-78. doi: 10.1158/1078-0432.CCR-09-2439. Epub 2009 Dec 22.

16.

Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies.

Cassidy J, Saltz LB, Giantonio BJ, Kabbinavar FF, Hurwitz HI, Rohr UP.

J Cancer Res Clin Oncol. 2010 May;136(5):737-43. doi: 10.1007/s00432-009-0712-3. Epub 2009 Nov 11.

17.

Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers.

Rohrbeck A, Neukirchen J, Rosskopf M, Pardillos GG, Geddert H, Schwalen A, Gabbert HE, von Haeseler A, Pitschke G, Schott M, Kronenwett R, Haas R, Rohr UP.

J Transl Med. 2008 Nov 7;6:69. doi: 10.1186/1479-5876-6-69.

18.

A methodology for the determination of reductive sulphur in optical and technical glass.

Rohr U, Meckea L, Strubel C.

Talanta. 2004 Jul 8;63(4):933-9. doi: 10.1016/j.talanta.2004.01.009.

PMID:
18969520
19.

Colonization of patients and contamination of the patients' environment by MRSA under conditions of single-room isolation.

Rohr U, Kaminski A, Wilhelm M, Jurzik L, Gatermann S, Muhr G.

Int J Hyg Environ Health. 2009 Mar;212(2):209-15. doi: 10.1016/j.ijheh.2008.05.003. Epub 2008 Jul 29.

PMID:
18667356
20.

Tumor immune escape by the loss of homeostatic chemokine expression.

Pivarcsi A, Müller A, Hippe A, Rieker J, van Lierop A, Steinhoff M, Seeliger S, Kubitza R, Pippirs U, Meller S, Gerber PA, Liersch R, Buenemann E, Sonkoly E, Wiesner U, Hoffmann TK, Schneider L, Piekorz R, Enderlein E, Reifenberger J, Rohr UP, Haas R, Boukamp P, Haase I, Nürnberg B, Ruzicka T, Zlotnik A, Homey B.

Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19055-60. Epub 2007 Nov 19.

21.

Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.

Diaz-Blanco E, Bruns I, Neumann F, Fischer JC, Graef T, Rosskopf M, Brors B, Pechtel S, Bork S, Koch A, Baer A, Rohr UP, Kobbe G, von Haeseler A, Gattermann N, Haas R, Kronenwett R.

Leukemia. 2007 Mar;21(3):494-504. Epub 2007 Jan 25.

PMID:
17252012
22.

The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells.

Neukirchen J, Meier A, Rohrbeck A, Garcia-Pardillos G, Steidl U, Fenk R, Haas R, Kronenwett R, Rohr UP.

Cancer Gene Ther. 2007 Apr;14(4):431-9. Epub 2007 Jan 19.

PMID:
17235352
23.

Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer.

Rehfeld N, Geddert H, Atamna A, Gabbert HE, Steidl U, Fenk R, Kronenwett R, Haas R, Rohr UP.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2232-8.

24.

Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma.

Papewalis C, Fassnacht M, Willenberg HS, Domberg J, Fenk R, Rohr UP, Schinner S, Bornstein SR, Scherbaum WA, Schott M.

Clin Endocrinol (Oxf). 2006 Aug;65(2):215-22.

PMID:
16886963
25.
26.

A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma.

Bruns I, Steidl U, Kronenwett R, Fenk R, Graef T, Rohr UP, Neumann F, Fischer J, Scheid C, Hübel K, Haas R, Kobbe G.

Transfusion. 2006 Feb;46(2):180-5.

PMID:
16441592
27.

The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer.

Rehfeld N, Geddert H, Atamna A, Rohrbeck A, Garcia G, Kliszewski S, Neukirchen J, Bruns I, Steidl U, Fenk R, Gabbert HE, Kronenwett R, Haas R, Rohr UP.

J Carcinog. 2006 Jan 20;5:4. doi: 10.1186/1477-3163-5-4.

28.

Use of RNA interference to inhibit integrin subunit alphaV-mediated angiogenesis.

Graef T, Steidl U, Nedbal W, Rohr U, Fenk R, Haas R, Kronenwett R.

Angiogenesis. 2005;8(4):361-72. Epub 2006 Jan 7.

PMID:
16400518
29.

WITHDRAWN: The safety of synthetic paclitaxel by intralesional delivery with OncoGeltrade mark into skin breast cancer metastases: method and results of a clinical pilot trial.

Rohr UD, Oberhoff C, Markmann S, Gerber B, Scheulen M, Schindler AE.

Arch Gynecol Obstet. 2005 Nov 29. [Epub ahead of print]

PMID:
16315026
30.

Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia vera.

Steidl U, Schroeder T, Steidl C, Kobbe G, Graef T, Bork S, Pechtel S, Kliszewski S, Kuendgen A, Rohr UP, Fenk R, Schroeder M, Haase D, Haas R, Kronenwett R.

Ann N Y Acad Sci. 2005 Jun;1044:94-108. Review.

PMID:
15958702
31.

Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles.

Rohr UP, Heyd F, Neukirchen J, Wulf MA, Queitsch I, Kroener-Lux G, Steidl U, Fenk R, Haas R, Kronenwett R.

J Virol Methods. 2005 Jul;127(1):40-5. Epub 2005 Apr 12.

PMID:
15893564
32.

Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy?

Beck V, Rohr U, Jungbauer A.

J Steroid Biochem Mol Biol. 2005 Apr;94(5):499-518. Epub 2005 Mar 23. Review.

PMID:
15876415
33.

Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer.

Grote HJ, Schmiemann V, Geddert H, Rohr UP, Kappes R, Gabbert HE, Böcking A.

Int J Cancer. 2005 Sep 20;116(5):720-5.

34.

Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.

Rohr UP, Rehfeld N, Geddert H, Pflugfelder L, Bruns I, Neukirch J, Rohrbeck A, Grote HJ, Steidl U, Fenk R, Opalka B, Gabbert HE, Kronenwett R, Haas R.

Clin Cancer Res. 2005 Jan 1;11(1):180-5.

35.

Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma.

Steidl U, Fenk R, Bruns I, Neumann F, Kondakci M, Hoyer B, Gräf T, Rohr UP, Bork S, Kronenwett R, Haas R, Kobbe G.

Bone Marrow Transplant. 2005 Jan;35(1):33-6.

PMID:
15531906
36.

Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma.

Fenk R, Hoyer B, Steidl U, Kondakci M, Graef T, Heuk R, Ruf L, Strupp C, Neumann F, Rohr UP, Hildebrandt B, Haas R, Kobbe G.

Leukemia. 2005 Jan;19(1):156-9. No abstract available.

PMID:
15510204
37.

Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer.

Rohr UP, Rehfeld N, Pflugfelder L, Geddert H, Müller W, Steidl U, Fenk R, Gräf T, Schott M, Thiele KP, Gabbert HE, Germing U, Kronenwett R, Haas R.

Int J Cancer. 2004 Aug 20;111(2):259-63.

38.

Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma.

Fenk R, Ak M, Kobbe G, Steidl U, Arnold C, Korthals M, Hünerlitürkoglu A, Rohr UP, Kliszewski S, Bernhardt A, Haas R, Kronenwett R.

Haematologica. 2004 May;89(5):557-66.

39.

Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators.

Steidl U, Bork S, Schaub S, Selbach O, Seres J, Aivado M, Schroeder T, Rohr UP, Fenk R, Kliszewski S, Maercker C, Neubert P, Bornstein SR, Haas HL, Kobbe G, Tenen DG, Haas R, Kronenwett R.

Blood. 2004 Jul 1;104(1):81-8. Epub 2004 Mar 11.

PMID:
15016651
40.
41.

Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector.

Rohr UP, Wulf MA, Stahn S, Heyd F, Steidl U, Fenk R, Opalka B, Pitschke G, Prisack HB, Bojar H, Haas R, Kronenwett R.

Cancer Gene Ther. 2003 Dec;10(12):898-906.

PMID:
14712316
43.

Progesterone increase under DHEA-substitution in males.

Nadjafi-Triebsch C, Huell M, Burki D, Rohr UD.

Maturitas. 2003 Jul 25;45(3):231-5.

PMID:
12818469
44.

High and low response in relation to nitric oxide formation but not to lipid peroxidation in patients with sepsis.

Schimke I, Richter N, Wauer H, Rohr U, Petersson AS, Wennmalm A, Kuppe H, Kox WJ.

Crit Care Med. 2003 Jan;31(1):65-72.

PMID:
12544995
45.

Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR.

Rohr UP, Wulf MA, Stahn S, Steidl U, Haas R, Kronenwett R.

J Virol Methods. 2002 Oct;106(1):81-8.

PMID:
12367732
46.

Primary human cells differ in their susceptibility to rAAV-2-mediated gene transfer and duration of reporter gene expression.

Rohr UP, Kronenwett R, Grimm D, Kleinschmidt J, Haas R.

J Virol Methods. 2002 Sep;105(2):265-75.

PMID:
12270659
47.

Inhibition of angiogenesis in vitro by alphav integrin-directed antisense oligonucleotides.

Kronenwett R, Gräf T, Nedbal W, Weber M, Steidl U, Rohr UP, Möhler T, Haas R.

Cancer Gene Ther. 2002 Jul;9(7):587-96.

48.

Melatonin deficiencies in women.

Rohr UD, Herold J.

Maturitas. 2002 Apr 15;41 Suppl 1:S85-104. Review.

PMID:
11955797
49.

IGF-1 in gynaecology and obstetrics: update 2002.

Druckmann R, Rohr UD.

Maturitas. 2002 Apr 15;41 Suppl 1:S65-83. Review.

PMID:
11955796
50.

The impact of testosterone imbalance on depression and women's health.

Rohr UD.

Maturitas. 2002 Apr 15;41 Suppl 1:S25-46. Review.

PMID:
11955793

Supplemental Content

Support Center